Osta Biotechnologies Inc. ("Osta"TSX-V:OBI) is a life sciences firm, currently focused on the development of Novel therapeutic products for Cancer and Alzheimer's disease. In addition, Osta has also developed a rich pipeline of novel therapeutic products for Osteoporosis and X-linked Hypophosphatemic Rickets (XLH). Osta's scientists are world-renowned clinicians, oncologists, bone biologists & neurologists with a proven track record of identifying, patenting and developing products and technologies for diseases affecting the aging population.